Industries · B2B healthcare · Life sciences

A life science marketing agency that gets your product into more labs

Marketing for research tools, instruments, lab software, CROs and CDMOs. Your buyers have PhDs and procurement logins, and they check claims against the literature.

A senior team that does the homework, pay as you go, no lock-in. Your first call is with a co-founder.

60+
high-potential sales interactions flagged per quarter with scientific enterprise accounts, alongside 10,000+ organic engagements. Cradle case study.
Healthcare and life science companies we've helped

Results across our scientific and healthcare work

10,000+
organic engagements within weeks of launching campaigns (Cradle)
60+
high-potential sales interactions flagged per quarter (Cradle)
27
engaged leads ready for sales follow-up (Coforix)
165
high-intent hospital contacts engaging on LinkedIn (Coforix)
The job

Why life science marketing needs a specialist

Selling into a lab means convincing the scientist, the lab manager and procurement, rarely in that order.

Purchases run at three speeds

42% of scientific purchases close within a month and 64% involve one to three people (AZoNetwork, 2026). Capital instruments and CRO qualification take quarters. One playbook can't serve both.

Discovery moved to search, then AI

Search engines influence 87% of scientific purchases and manufacturer websites 88%, while AI-assisted product comparison rose 68% in a year (AZoNetwork, 2026). Sales reps are a declining channel.

Citations outsell campaigns

A product named in the methods section carries more weight than any ad, and regions led by a trial's lead investigator adopt 36% more (Agha and Molitor, NBER). Named scientific authority moves markets.

Funding decides when labs buy

NIH grant obligations ran 42 to 44 days behind their usual pace into 2026, and academic demand stayed weak while pharma budgets recovered. The end market sets your calendar.

Problems we solve

Problems we solve for life science companies

First-call sentences from tools, lab software and services companies. If two are yours, keep reading.

“Our growth plan assumed academic budgets that no longer exist.”
What we hear
Repositioning toward pharma and applied markets, with campaigns for the segments that still close fast.
What we do
“Scientists find us through a method search, and our product pages don't answer it.”
What we hear
Spec-complete product pages and application notes built against the method searches buyers actually run.
What we do
“Procurement knows our catalog number. Nobody above the lab manager knows our name.”
What we hear
‍Visibility where decisions escalate: PI-level content, citations and the conferences that matter in your field.‍
What we do
“Our content is too technical for buyers or too shallow for scientists.”
What we hear
Method-level content drafted with your scientists and sourced like a paper, then layered for each reader.
What we do
“The pipeline is two reps and a booth at SLAS.”
What we hear
A search and AI-visibility layer that captures demand year-round, plus conference programs that outwork the booth.
What we do
“We need marketing that can read a protocol.”
What we hear
Senior people who do the homework: your methods, your buyers' workflows and the literature around both.
What we do

Approach

Life science digital marketing that scientists trust

As a life science digital marketing agency, we run content, search, conferences and channel work as one function, with people who can read a protocol.

Application notes and protocol content

Method-level content drafted with your scientists and sourced like a paper: application notes, troubleshooting guides, technique explainers. It answers the questions your buyers arrive with, and it is the format AI search engines cite when they answer for you.

Search and AI visibility for technical queries

Spec-complete product pages built against method, application and comparison searches. With search influencing 87% of scientific purchases and AI comparison up 68% in a year, the demand-capture layer is your documentation, so we treat it as campaign material.

Conference programs that outwork the booth

Trade shows are the largest marketing cost line in life sciences, so we make the spend compound: pre-booked meetings against a named-account list, side events, and follow-through that turns SLAS, ACHEMA or BIO scans into evaluations.

Distributor and reseller enablement

Where a distributor owns your DACH or APAC revenue, we arm the channel: co-branded campaigns, product data and claims they can reuse, and demand programs that make your catalog the easiest one in their bag to sell.

Vendor-qualification support for CROs and CDMOs

Therapeutic-area positioning, since expertise is the top selection criterion for small sponsors, plus RFI and bid-defense materials and audit-ready documentation. The goal is being credible at the exact moment a consultant or peer builds the shortlist.

The rule we work by

If it wouldn't survive the methods section, it doesn't go in the campaign.

Results

Results for scientific buyers

We work with companies whose buyers are scientists and clinicians, from AI protein design to hospital software. Here's what two of them have seen.

TechBio
Cradle builds AI for protein design, used by computational scientists and experimental biologists. Campaigns drew 10,000+ organic engagements within weeks, and 60+ high-potential sales interactions are flagged each quarter.
10,000+
organic engagements
60+
sales interactions per quarter
MedTech
Coforix sells certified AI products to hospitals. We came in as its first marketing function and took it from no campaigns to 27 engaged leads ready for sales follow-up and 165 high-intent hospital contacts.
27
engaged leads ready for sales
165
high-intent hospital contacts

What Do they say?

We like to let our customers do the talking.

Your journey

Your first 90 days,
week by week

We don’t like to work from templates. Your Head of Growth builds the strategy around your products, your buyers and how labs evaluate suppliers. The cards below show one example for a health tech company.

Kick off
●
Day 0

We meet your founders, commercial lead and application scientists, get access to the website, CRM and analytics, and agree what counts as a qualified request from a lab.

Onboarding
KPI alignment
Ysabel CamusBerk Kalyoncu
Full audit
●
Weeks 1-2

We audit the website, search and AI-search visibility, paid accounts and tracking. With your sales team, we go through recent won and lost deals and check your product pages against the method and application searches your buyers run.

Website and search
Product pages
Won and lost deals
Michaela RiesBerk KalyoncuYsabel Camus
Strategy & workshops
●
Weeks 3-4

Working sessions with your commercial, product and science leads. You leave with a plan written for your company: which segments come first, who decides in each lab and which channels we use to reach them.

Segment priorities
Buyer map
Channel plan
Ysabel CamusMichaela RiesBerk Kalyoncu
Quick wins
●
Weeks 4-5

We fix tracking and the quote and demo request flow, cut ad spend that reaches the wrong audience, and add missing specifications and application data to the product pages that already get traffic.

Request flow
Ad fixes
Product pages
Berk KalyoncuAlexandru Cojuhari
Product pages go live
●
Week 6+

Rebuilt product and application pages go onto the website, each with the specifications, protocols and comparison data a scientist will want to check.

Specifications
Application pages
Comparison pages
Michaela RiesDaniela GutuAlexandru Cojuhari
Application notes
●
Week 6+

We interview your scientists and publish under their names: application notes, troubleshooting guides and technique explainers, written at the level of detail a method section would have.

Scientist bylines
Application notes
Search and AI search
Michaela RiesYsabel Camus
Named-account campaigns
●
Week 6+

Account-based campaigns on LinkedIn and paid search for an agreed list of target accounts, with separate messages for the scientist, the lab manager and procurement.

Target account list
LinkedIn
Paid search
Berk KalyoncuYsabel Camus
Conference plan
●
Week 6+

Ahead of the conferences that matter in your field, we book meetings with target accounts, prepare the follow-up and make sure booth conversations end up in the CRM.

Pre-booked meetings
Follow-up
CRM
Ysabel CamusDaniela Gutu
First pipeline report
●
Month 3

One report for your leadership team shows which target accounts engaged, how many quote, demo and evaluation requests came in, and what we recommend for the next quarter. Fast consumables deals and slower capital or services deals are reported separately.

Account engagement
Requests by segment
Next-quarter plan
Ysabel CamusBerk Kalyoncu
?
After day 90

Your Head of Growth goes through the results with you and adjusts the plan. Work that led to conversations with buyers gets more budget, and the rest is paused.

Review with you
Plan adjusted

Selling to science is not one market

The buyer and the evidence bar change with what you sell, so each market keeps its own page.

You are here

Life sciences

Research tools, instruments, reagents, lab software, CROs and CDMOs, sold to scientists, lab managers and procurement. Proof bar: citations, protocols, batch consistency.

Making the science

Biotech and TechBio

Platforms and therapeutics developers selling science to pharma R&D and investors. Proof bar: peer-reviewed publication. Client: Cradle.

Hardware for the clinic

Medical devices

Devices and diagnostics hardware sold through procurement and value analysis committees. Proof bar: clinical data plus a per-procedure economic case.

Who you'll work with

EU and US teams, with Boston, the Bay Area, Basel and Cambridge on the target map. The senior people who scope the work stay on it.

Team
Ysabel Camus
Head of Growth
James Eisner
James Eisner
Head of Growth
Michaela Ries
SEO / GEO Lead
Berk Kalyoncu
Berk Kalyoncu
Performance Specialist
Daniela Gutu
Daniela Gutu
Graphic Designer
Alexandru Cojuhari
Alexandru Cojuhari
Front End & Web Developer
André Antunes
André Antunes
RevOps & AI Lead
Daniel Bilici
Daniel Bilici
Sr. Growth Marketing Manager
Read our report · The State of Marketing in Health Tech

How scientific and clinical buyers decide, from people who sell to them.

The State of Marketing in Health Tech 2026 report cover

We interviewed six practitioners for this report: the co-founder and CEO of a hospital AI company who spent a decade at Philips, the Head of AI at a company that predicts migraines from wearable data, and four of our own Heads of Growth and co-founders. We then checked what they said against OECD, WHO and European Commission data and peer-reviewed research. It was written for health tech, and most of what it says about evidence, buying committees and channels applies to anyone selling to scientists.

44%
of 224 digital health companies had no published clinical evidence (JMIR, 2022)
36%
higher early uptake of a drug near its lead investigator (Agha and Molitor, NBER)
3–6
months for a research institute to buy, against six months to five years in pharma (our interviews)
Read the report
No form, and in ten minutes you'll know whether we read your market the way you live it.
FAQ

Choosing a life sciences marketing agency: questions we get asked

Where we work

Amsterdam and New York, serving life science companies across Europe and the US, with Boston, the Bay Area, Basel and Cambridge as target hubs.

What does a life science marketing agency do?
Is life science marketing the same as biotech
marketing?
Should we hire a life sciences marketing consultant or an agency?
How do you build a lead generation system for a life science company?
How do you market to scientists without oversimplifying?
Do you work with CROs and CDMOs?
How does life science SEO work for technical searches?
What does it cost, and how fast do results come?

Your first call is with a co-founder

The call is 30 minutes with the founder who has the most experience in your industry.

Book a 30-minute call